The microbial pattern-recognizing Toll-like receptors (TLRs) are major signal transducers known to shape and influence the postnatal maturation of host intestinal epithelium. Perturbations in this intricate host-microbe cross-talk have been reported to be associated with uncontrolled epithelial cell growth and thus potential cancer development by mechanisms which are largely unknown. We therefore generated transgenic mice carrying a constitutively active TLR4 (CD4-TLR4) linked to an intestinal epithelial cell-specific promoter. Ex vivo analysis of transgenic crypt-villus organoid cultures revealed an increased proliferative capacity and a lowered cyclooxygenase 2 (Cox-2) expression in these organoids compared with wild-type control cultures. Introducing the CD4-TLR4 transgene into APC Min/ þ mice (CD4-TLR4-APC Min/ þ ), a model of colorectal carcinoma, resulted in a dramatic drop in tumor load as compared with control APC Min/ þ mice. Intestinal tumors from CD4-TLR4-APC Min/ þ mice displayed reduced Cox-2 protein, elevated interferon b expression and increased caspase-3 activity, which correlated with increased apoptosis in vivo. Thus, our data reveal that host microbiota-mediated signal transduction via TLR4 in intestinal epithelial cells is far more complex than what is previously reported.
INTRODUCTION
Toll-like receptors (TLRs) are a family of pattern recognition receptors known to regulate host defense against infection, intestinal homeostasis and mucosal innate immune functions. Through their ability to recognize pathogen-associated molecular patterns found on microbes, TLRs transduce signals from the luminal surface to the intestinal mucosal layer. One major TLR involved in the sensing of Gram-negative enteric bacteria and their products such as lipopolysaccharide (LPS) is TLR4. Several studies involving a variety of microbial products and TLR4 agonists have implicated the critical role of TLR4 signalling in the regulation of tumor growth, survival and progression.
In the APC Min/ þ mouse model of spontaneous intestinal tumorigenesis, genetic ablation of MyD88, a downstream signalling adapter of TLRs, resulted in the reduction of small intestinal tumor frequency and size. 1 This finding thus suggests the potential role of microbial signalling, of which the TLR4 cascade is a major component, in promoting intestinal tumorigenesis, via the MyD88-dependent signalling pathway. Further evidence supporting the positive role of TLR4 in cancer development was demonstrated in a variety of adoptively transferred tumors, where LPS was found to augment tumor growth and metastasis. [2] [3] [4] While TLR4 signalling has been shown to drive tumorigenesis, recent accumulating evidence has also pointed to an antitumor effect of TLR4 activation. Potent anticancer effects against adoptively transferred tumors in mice have been illustrated with the administration of LPS. 5, 6 Moreover, the administration of LPS and two other potent TLR4 agonists, OK-432 and Mycobacterium bovis bacillus Calmette-Gué rin, have been shown to be effective in the treatment of various carcinomas, such as colorectal, gastric, bladder and lung cancer. [7] [8] [9] [10] This negative regulatory role of TLR4 in cancer recapitulates the earlier work by William Coley in the 19th century, where repeated injections of bacterial toxins, later found to be LPS, were effective as an anticancer therapeutic. 11 Thus, the role of TLR4 signalling in tumor development is complex and warrants further investigation.
One major mediator of tumor growth and survival is cyclooxygenase 2 (Cox-2). Cyclooxygenases, also known as prostaglandin-endoperoxide synthases (PTGS), are important enzymes that catalyze the synthesis of prostaglandins from arachidonic acid. 12 To date, there are two known isoforms of cyclooxgenases, Cox-1 and Cox-2, which are differentially expressed and regulated. In contrast to Cox-1, which is expressed ubiquitously in most tissues and generally considered to contribute to cellular homeostasis, Cox-2 expression is rapidly induced by inflammatory mediators, growth factors, oncogenes and endotoxins. 12 Cox-2 is a known critical player of cancer progression in various aspects, including cell proliferation and migration, apoptosis, tumor angiogenesis and metastasis. 13, 14 In the context of colorectal cancer, usage of Cox-2 inhibitors has been efficacious in the treatment of familial adenomatous polyposis patients. 15, 16 Our recent work as well as studies by other groups has highlighted the crucial role of TLR4 stimulation in promoting tumor cell proliferation and survival in vitro. [17] [18] [19] Thus in this current study, we were interested to understand how TLR4 signalling influences intestinal homeostasis in vivo, in particular, the development of intestinal tumors arising from a genetic 1 Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institute, Stockholm, Sweden; predisposition such as the APC Min/ þ mouse model. 20 In our investigation, we developed APC Min/ þ mice expressing constitutively active TLR4 (CD4-TLR4) specifically in the intestinal epithelium. Interestingly, CD4-TLR4-expressing APC Min/ þ mice displayed reduced tumor burden in the intestine, and their small intestinal tumors showed increased apoptosis in vivo that correlate with Cox-2 downregulation. Our findings thus shed light on an unrecognized role of long-term epithelial TLR4 activation in the inhibition of tumorigenesis in the intestine, through upregulation of apoptotic signals in a genetically susceptible environment.
RESULTS

Constitutive epithelial TLR4 signalling suppresses APC
Min/ þ intestinal tumorigenesis In our recent study of APC Min/ þ mice, we established microbial signalling as a major mediator of intestinal tumorigenesis. 17 This finding complements previous work from Medzhitov's group, whereby deletion of MyD88 resulted in a dramatic reduction of tumor burden in APC Min/ þ mice. 1 Moreover, we further identified TLR4, a key component of microbial signalling, as a regulator of tumor cell proliferation. 17 We thus sought to further dissect its role in intestinal tumorigenesis in vivo. To address this, we generated transgenic mice expressing CD4-TLR4, which comprised of murine CD4 ectodomain fused to constitutively active domains of human TLR4, specifically in intestinal epithelial cells. 21 Analysis of various intestinal segments by RT-PCR and quantitative real-time PCR (Q-PCR) showed that CD4-TLR4 transgenic mice express the transgene throughout the gut as early as 4 weeks of age (Supplementary Figure 1A) , with highest expression levels occurring predominantly in the proximal small intestine and colon (Supplementary Figure 1B) . Immunostaining of intestinal sections with anti-mouse CD4 antibody verified epithelial localization of fusion protein in transgenic but not in control mice (Supplementary Figure 1C) . The CD4-TLR4 mice had normal lifespan and did not exhibit abnormalities in intestinal morphology or abnormal influx of inflammatory cells (Supplementary Figure 1D) . Thus, constitutive TLR4 signalling in intestinal epithelia does not induce spontaneous inflammation nor affect intestinal function and morphology.
We next crossed CD4-TLR4 mice with APC Min/ þ mice, and analyzed for tumor load in the intestines of these mice. Unexpectedly, we found that APC Min/ þ mice expressing constitutively active TLR4 developed significantly fewer tumors in small intestine than APC Min/ þ mice at both 16 and 28 weeks of age (P ¼ 5.432e-05 and P ¼ 0.0023, respectively, Mann-Whitney) (Figure 1a ; Supplementary Figure 2A) . Mean tumor size was also significantly reduced in these mice as compared with agematched APC Min/ þ mice at 16 weeks of age (P ¼ 1.881e-12, Mann-Whitney test) (Figure 1b ).
Transgene expression enhances Paneth cell functions leading to increased epithelial growth in long-term ex vivo cultures. As we were surprised by the dramatic reduction of tumor load in CD4-TLR4-APC Min/ þ mice, we examined whether long-term, in vivo, epithelial TLR4 stimulation influenced intestinal epithelial proliferation. Immunohistochemical analysis of Ki-67 revealed increased nuclear staining in intestinal epithelial cells residing above crypt bases of CD4-TLR4 mice as compared with WT mice (Figure 2a) , indicating a higher proliferative status of the intestinal epithelium during persistent TLR4 activation.
We then sought to investigate how constitutive epithelial TLR4 signalling can influence the stem cell compartment, thus impacting on epithelial proliferation. As Paneth cells have been demonstrated to be critical for producing essential niche signals for Lgr5 þ intestinal stem cells, 22 we checked our CD4-TLR4 mice for Paneth cell functions. Periodic acid-Schiff staining of intestinal segments of WT and CD4-TLR4 mice showed more abundant staining of Paneth cell-like cells at colonic crypt bases as well as goblet cells at colonic crypts of CD4-TLR4 mice as compared with age-matched, WT counterparts (Supplementary Figure 3) . In contrast, we did not detect visible differences in Paneth cells and goblet cells amounts in the small intestines of CD4-TLR4 and WT mice (Supplementary Figure 3) . Consistent with increased Paneth cell levels, CD4-TLR4 mice expressed elevated mRNA levels of antimicrobial peptides, cryptdin-1 and lysozyme, in colonic mucosal scrapings as compared with WT mice, that correlated with high expression levels of transgene (48-fold induction compared with lowest transgene expressing sample) (Po0.01, Mann-Whitney) (Figure 2b ). Similar observations were found for relative expression levels of Wnt1 and Wnt3, which are known to be produced by Paneth cells 23 (Po0.01, Mann-Whitney) ( Figure 2b ). The expression levels of proliferating cell nuclear antigen (PCNA) between WT and CD4-TLR4 colonic mucosal scrapings were however not significantly different (Figure 2b ).
To more precisely examine whether increased Paneth cell activity and persistent TLR4 stimulation had a proliferative impact on the intestinal epithelium, we purified intestinal crypts from CD4-TLR4 and WT mice and cultured them ex vivo for 5 days using an established matrigel-based culture system. 22 As regions S1-3 of the small intestines of CD4-TLR4 mice express the highest levels of transgene (Supplementary Figure 1B) , we used S1-3 intestinal segments from both CD4-TLR4 and WT mice. We found that while the ability to form viable crypt-villus organoids a day after initial plating did not differ between CD4-TLR4 and WT intestinal crypts, CD4-TLR4 organoids appeared to be larger and more viable than WT organoids after 5 days of culture, forming new crypts from budding sites (Figure 3a) . Moreover, Ki-67 staining showed denser We further performed Q-PCR expression analyses of our cryptvillus organoid cultures after 5 days and observed that CD4-TLR4 organoids maintained elevated levels of Paneth cell markerscryptdin-1, lysozyme and Wnt3 in comparison with WT organoids (Figure 3c ), similar to our earlier findings from mucosa scrapings ( Figure 2b ). Interestingly, a strong induction of Lgr5 and PCNA was observed in CD4-TLR4 organoids as compared with WT organoids (Figure 3c ), which is consistent with the current notion that increased Paneth cell levels promote the maintenance and development of intestinal stem cells, as well as epithelial cell growth.
We then asked whether increased Paneth cell activity in CD4-TLR4 organoids was due to constitutive TLR4 stimulation in Paneth cells by performing FACS sorting of CD24 þ Paneth cells from purified intestinal crypts of CD4-TLR4 mice and probing for transgene expression in sorted Paneth cells. As shown in Supplementary Figure 4 , sorted CD24 high cells (P8 fraction) were found to express elevated levels of Paneth cell markers-cryptdin-1, lysozyme and defcr-rs-10 as compared with CD24 low cells (P5 and P6 fractions). Notably, sorted CD24 high Paneth cells expressed higher levels of transgene than CD24 low cells (Supplementary Figure 4B) .
Taken together, our findings demonstrate that constitutive TLR4 signalling in the intestinal epithelium drives epithelial cell proliferation through enhanced Paneth cell functions in vivo. Moreover, CD4-TLR4 organoids expressed higher levels of chromogranin A and mucin 2 that are known markers of enteroendocrine and goblet cells, respectively (Figure 3c ), demonstrating that persistent epithelial TLR4 activation leads to enhanced functions of all secretory lineages in the intestine.
Reduced Cox-2 expression correlates with increased apoptosis in CD4-TLR4-expressing intestinal tumors While we observed that increased proliferation in ex vivo organoid cultures correlated with active TLR4 signalling, we were surprised to find reduced Cox-2 levels in CD4-TLR4 organoids ( Figure 3c ). As Cox-2 is an important player of tumorigenesis, [24] [25] [26] (Figure 4d ). Meanwhile, increased mucin 2 expression was observed in CD4-TLR4-APC Min/ þ tumors while chromogranin A levels remained unchanged (Figure 4d ). We also checked the protein levels of two major proliferation markers-Ki-67 and c-Myc in tumors and did not find significant differences (Supplementary Figures 6A and C) .
As Cox-2 is known to promote tumor cell survival through inhibition of apoptosis, 13, 14 we probed whether Cox-2 downregulation in CD4-TLR4-expressing mice increased levels of apoptosis in vivo. We injected WT and CD4-TLR4 mice, as well as APC Min/ þ and transgene-expressing APC Min/ þ mice with FAM-FLIVO, a green fluorescent probe (carboxyfluorescein) that binds irreversibly to active caspases, 28 and analyzed for levels of apoptotic cells in normal mucosa and tumor tissues of the small intestine. We found that while small intestinal tumors did not appear histologically different between WT and CD4-TLR4-expressing APC Min/ þ mice (Figure 5a ), levels of apoptotic cells in CD4-TLR4-APC Min/ þ tumors were markedly higher than agematched, non-transgenic APC Min/ þ mice (Figures 5b and c ; Po0.001, Mann-Whitney). In contrast, no significant differences in levels of apoptotic cells were observed in the normal mucosa of CD4-TLR4 mice as compared with age-matched WT mice (Supplementary Figure 7) . Moreover, CD4-TLR4-APC Min/ þ tumors expressed significantly higher protein levels of cleaved caspase 3 ( Figure 5d ). Collectively, these findings thus demonstrate an elevated level of apoptosis in CD4-TLR4-expressing intestinal tumor cells in vivo that correlate with Cox-2 downregulation.
DISCUSSION
The interaction of commensal microflora with the host via TLR signalling is critical not only for host defense against pathogens, but also for gut epithelial homeostasis. Thus in our study, we employed constitutively active TLR4 as an experimental approach to simulate host-microbe signalling in vivo and in turn understand its role in regulating epithelial homeostasis and tumorigenesis. Through introduction of epithelial CD4-TLR4 in the APC Min/ þ mouse model of intestinal tumorigenesis, our findings reveal the intricate balance between epithelial proliferation and apoptosis that is regulated by microbial signalling. This fine equilibrium of proliferation versus programmed cell death modulates aberrant epithelial cell growth and hence the development of intestinal tumors.
In our study, we found that persistent epithelial TLR4 activation impacts on Paneth cell functions, as well as all other secretory cell lineages in the intestine, thus regulating epithelial cell growth and intestinal homeostasis. While constitutive TLR4 signalling results in an increased proliferative status of the intestinal epithelium, a higher extent of apoptosis also ensues in a genetically predisposed environment, possibly through downregulation of critical survival factor, Cox-2. Thus as an indirect consequence of constitutive TLR4 signalling, the turnover rate of transformed intestinal epithelial cells is enhanced and this disrupted balance of proliferation versus apoptosis tips over toward the latter, leading to the suppression of APC Min/ þ -driven spontaneous tumorigenesis. Using the APC Min/ þ mouse model of spontaneous intestinal tumorigenesis, we found that the expression of constitutively active TLR4 in intestinal epithelium results in the suppression of intestinal tumor outgrowth (Figure 1; Supplementary Figure 2A) . Although mice transgenic for CD4-TLR4 in the intestinal epithelium, that is, villin-TLR4 mice have been studied previously in a colitis-associated neoplasia model, 29 we used a different promoter, the intestinal fatty acid binding protein promoter, which is only activated when differentiating enterocytes leave the crypts and migrate to the base of small intestinal villi or surface of colonic epithelia. 30, 31 As such, in contrast to the villin promoter, intestinal fatty acid binding protein promoter circumvents interference of the active transgene with stem cell development and early differentiation of the four epithelial lineages at intestinal crypt bases.
While we were surprised to find a remarkable reduction of tumor burden in CD4-TLR4-expressing APC Min/ þ mice (Figure 1;  Supplementary Figure 2) , our data from intestinal mucosal tissues and ex vivo organoid cultures support current, cumulative evidence for the major contribution of TLR4 signalling in epithelial cell proliferation. 3, 4, 17, 18 Notably, we found that constitutively active epithelial TLR4 resulted in increased proliferating cells (Figure 2a ) correlating with increased Paneth cells (Supplementary Figure 3) and elevated expression of Paneth cell markers (cryptdin-1 and lysozyme) and Wnts in the intestine (Figure 2b ). This increased proliferative status was further recapitulated in our ex vivo organoid cultures (Figure 3) . Meanwhile, this increased proliferative capacity did not result in aberrant crypt outgrowth in the transgenic mice (Supplementary Figure 1D) , suggesting that additional regulatory signals, such as enhanced functions of all secretory cell lineages (Figure 3c ), are in place to prevent aberrant epithelial growth and maintain normal intestinal homeostasis.
Interestingly, constitutive TLR4 activation did not induce profound differences in tumor proliferation as visualized by Ki-67 and c-Myc levels (Supplementary Figure 6) . We further checked for alternative mechanisms regulating tumor growth and survival such as IL-6 production and autophagy. While IL-6 mRNA was upregulated in CD4-TLR4-APC Min/ þ tumors (Supplementary Figure 8A) , this trend was not reflected at the protein level (Supplementary Figure 8B) . Intriguingly, expression of a TLR4-inducible RNase, Zc3h12a, which is known to degrade IL-6 mRNA, 32 was increased in CD4-TLR4-APC Figure 6B) . Thus, constitutive TLR4 stimulation does not affect proliferation in APC Min/ þ tumors. While we observed proliferative effects associated with active TLR4 stimulation in normal mucosa, one intriguing finding arising from our ex vivo organoids culture work was the regulation of TLR4 on Cox-2 expression. Although current cumulative evidence supports the notion that TLR4 induces Cox-2 expression in both intestinal epithelial cells and lamina propria stromal cells as an important homeostatic response triggered during inflammatory stimulation, 33, 34 our study suggests that chronic stimulation of TLR4 in intestinal epithelial cells may lead to the downregulation of Cox-2 instead (Figure 3c ).
This interesting phenomenon provides a plausible mechanism underlying the reduced tumor load observed in our CD4-TLR4-APC Min/ þ mice ( Figure 1 ; Supplementary Figure 2A) . We found significantly reduced levels of Cox-2 expression in intestinal tumors from CD4-TLR4-APC Min/ þ mice as compared with tumors from APC Min/ þ mice, which correlated with high transgene expression (Figures 4a and b; Supplementary Figure 5 ). This finding thus supports the role of Cox-2 inhibitors in the amelioration of intestinal tumors in APC Min/ þ mice as well as in familial adenomatous polyposis patients. 15, 16 Moreover, other epithelial models of Cox-2 overexpression using both cancer cell lines and transgenic mice have demonstrated the role of Cox-2 in promoting tumor development. 35, 36 Accumulating evidence has pointed to the significant contribution of Cox-2 in tumor promotion by imparting resistance to apoptosis. 13, 14 One study has also reported that mice expressing the CD4-TLR4 construct under a different epithelial promoter developed significantly more azoxymethane-induced tumors when mucosal Cox-2 levels were significantly upregulated by repeated cycles of DSS-induced colitis. 29 In contrast, our in vivo studies of CD4-TLR4-APC Min/ þ mice support the role of Cox-2 in the regulation of apoptosis when mere TLR4 activation in Constitutively active TLR4 regulates tumorigenesis Y Li et al epithelial cells is not supported by concomitant inflammation. Notably, the downregulation of Cox-2 in CD4-TLR4-expressing intestinal tumors was closely associated with an increased expression of apoptotic markers-Bad and p21 (Figure 4c ). This increased apoptotic potential was further highlighted in vivo by a marked increase in apoptotic cells per tumor area and levels of activated caspase 3 in the small intestinal tumors of CD4-TLR4-APC Min/ þ mice (Figures 5b-d) , thereby suggesting that Cox-2 inhibition promotes the apoptosis of intestinal epithelial cells leading to decreased survival of CD4-TLR4-APC Min/ þ tumors. Interestingly, the expression of IFNb1, a key host defense cytokine against pathogens including microbes and tumor cells, is also upregulated in these CD4-TLR4 tumors (Figure 4b ). While IFNb has been recently identified to be produced by TLR4-activated tumor cells as a critical mediator of antitumoral immune response, 27 the synergistic effect of Cox-2 inhibitor and IFNb in the induction of apoptosis has been demonstrated previously to be efficacious in tumor cell lines and xenotransplanted tumors. 37 Moreover, IFNb has been shown to inhibit Cox-2 expression at the transcriptional level in intestinal epithelial cells. 38 These findings thus provide a possible mechanism for increased apoptosis in CD4-TLR4 tumors, resulting in overall suppression of intestinal tumorigenesis. This reduced tumor burden of CD4-TLR4-APC Min/ þ mice was in spite of enhanced mucosal expression of growth factors (Wnts), and Paneth cell functions that support epithelial cell proliferation. In conclusion, our observations thus put forth an interesting notion that TLR4 signalling is not inevitably associated with tumor growth and reveal that other regulatory mechanisms triggered by TLR4 activation within the host have to be taken into consideration when we evaluate the impact of microbiota on tumor growth.
MATERIALS AND METHODS
Animal studies
CD4-TLR4 transgenic mice were generated using the mCD4-TLR4 fusion gene (a gift from Dr Medzhitov), 21, 39 which comprises a constitutively active human TLR4 cytoplasmic domain fused to the extracellular domain of murine CD4, under the control of intestinal epithelial cell-specific fatty acid binding (intestinal fatty acid binding protein) promoter in a similar procedure as described previously. 40 Verification of transgenic mice was performed by PCR amplification of genomic DNA using the following primers: 5 0 -CGCTTCAGTTTGCTG-3 0 , 5 0 -CCGGGAATAAAGTCTCT-3 0 . Mice were backcrossed to C57BL/6 mice for over 10 generations. To introduce APC Min/ þ mutation, CD4-TLR4-positive females were paired with APC Min/ þ males. Mice of the first generation derived from these crosses were used to assess tumorigenesis. For tumor counting, whole intestine was fixed in phosphate-buffered saline (PBS)-buffered 4% formalin solution and cut longitudinally. Only clearly defined adenomas exceeding 0.8 mm were counted as tumors under the dissection microscope. Mice were maintained under specific pathogen-free conditions. All animal experiments were performed following Swedish ethical regulations and guidelines of the Institutional Animal Care and Use Committee of SingHealth Office of Research.
Reverse-transcription PCR and Q-PCR
Total RNA from mucosal scrapings of different intestinal segments was extracted using the RNeasy mini kit (Qiagen) according to manufacturer's instructions. In all, 2 mg total RNA was used for cDNA synthesis using Superscript II (Invitrogen, Carlsbad, CA, USA). Transgene expression was analyzed via PCR amplification of 2.5 ml cDNA using primers specific for murine CD4 and human TLR4: 5 0 -GGTTCTGGCAACCTGACTCT-3 0 and 5 0 -CCCACTGTTCCTTCTGGATT-3 0 . Q-PCR was performed in triplicates for each sample on a ABI 7500 Real time PCR System (Applied Biosystems, Carlsbad, CA, USA) using Fast SYBR Green PCR Mastermix (Applied Biosystems). Mouse primer sequences for the various genes described in the study are presented in Supplementary  Table 1 . Q-PCR data are presented as fold change of relative gene expression using b-actin as endogenous control.
Immunostaining
Colonic tissues from CD4-TLR4 and wild-type (WT) mice were freshly embedded in Tissue-Tek OCT (Sakura Finetek, The Netherlands), snap frozen and sectioned on a cryostat. Sections were blocked in 10% mouse serum for 30 min at room temperature before incubating with CD4 antibody (BD Pharmingen, San Diego, CA, USA, 550278) at 1:50 dilution for 1 h at room temperature. The slides were then washed in PBS and incubated with Alexa Fluor 488 goat anti-rat IgG (Invitrogen, A11006). DAPI (4',6-diamidino-2-phenylindole) was used for nuclear staining. For staining with Ki-67 antibody (Leica, Newcastle, UK, NCL-Ki-67-MM1), formalin-fixed intestinal tissues from CD4-TLR4 and WT mice were used. Sections were deparaffinized in Bond Dewax solution (Leica) before performing antigen retrieval using Bond Epitope Retrieval Solution (Leica).
Crypt isolation, cell dissociation and culture S1-3 small intestinal segments (refer to Supplementary Figure 1B for classification) from CD4-TLR4 and WT mice were collected for crypt isolation and culture as described previously. 41 In all, 6000 crypts per well on 48-well plates were cultured as described previously. 41 For culture experiments, four independent experiments were performed. For each culture/sorting experiment, crypts were pooled from 2 to 5 intestines. At day 6 from initial plating of crypts, total RNA was isolated from cultures using Trizol LS reagent (Invitrogen) according to manufacturer's recommendations.
For sorting of Paneth cells, crypts were dissociated with 0.5 Â trypsin for 40 min at 37 1C, passed through a 40-mm cell strainer (BD) and washed with PBS/2% FBS (fetal bovine serum). Cells were incubated with anti-CD24 antibody (BD Pharmingen, 553260) for 50 min at 4 1C, washed with PBS/2% FBS and then incubated with Alexa-fluor goat anti-rat IgG for 30 min at 4 1C. Viable epithelial single cells were gated by forward scatter, side scatter and pulse-width parameter, and negative staining for DAPI. Cells were collected in cold PBS containing 20% FBS, and total RNA was extracted using Arcturus PicoPure RNA isolation kit (Life technologies, Carlsbad, CA, USA) according to manufacturer's instructions.
In vivo apoptosis assay
To detect apoptosis in vivo, CD4-TLR4-APC Min/ þ and APC Min/ þ mice were injected intravenously with FAM-FLIVO (Immunochemistry, 981) via tail vein 1 h before kill and harvesting of intestinal tissues. Whole intestines were fixed in PBS-buffered 4% formalin solution and cut longitudinally. Tissues sections of tumors and normal epithelia were subsequently made and apoptotic cells were visualized under a fluorescence microscope at an excitation wavelength of 488 nm. At least 10 different small intestinal tumors and 60 non-overlapping microscopic fields of view under a 20 Â objective from each group were analyzed and counted for apoptotic cells.
Immunoblotting
Small intestinal tumors were extracted under dissection microscope and prepared in lysis buffer (20 mM Tris pH 8, 150 mM NaCl, 1 mM EDTA, 1% Triton X, 1 mM DTT), supplemented with protease inhibitors (Roche, Mannheim, Germany). Samples were subjected to SDS gel electrophoresis and western blotting, using 50 mg of protein extracts per lane. 
Statistical analysis
GraphPad Prism 5 was used for all statistical tests performed in this study.
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